But Trump is also taking a vaccine-like drug made by Regeneron Pharmaceuticals, a promising covid-19 treatment.
Researchers are using Regeneron’s experimental antibody drug in a very different way: They’re giving it to patients with only mild symptoms.
Many experts view the drug as the best bet to stymie the coronavirus and transform it from a potentially lethal disease into a treatable illness.
“This drug, called a monoclonal antibody cocktail, aims to keep people out of the hospital altogether,” my colleague Carolyn Y. Johnson wrote recently. “The experimental shot of lab-generated antibodies imitates the body’s own disease-fighting force. The goal is to boost a person’s immune defense, instead of waiting for human biology to muster its own response — and possibly lose to the virus.”
The antibodies are grown in rodents that are genetically engineered to have humanized immune systems, Carolyn explains.
Last week, Regeneron announced its drug appeared effective against